Beverly JCG Ltd. Shareholders Approve Major Acquisition, Issuance of Securities, and Name Change to Beverly Wilshire Ltd. – What Investors Must Know

EGM Delivers Transformative Decisions That Could Reshape the Future of Beverly JCG Ltd.

Beverly JCG Ltd. (soon to be Beverly Wilshire Ltd.) held an Extraordinary General Meeting (EGM) on September 8, 2025, resulting in unanimous shareholder approval for several sweeping resolutions. These decisions, covering a strategic acquisition, issuance of new securities, a transfer of controlling interest, and a corporate rebranding, could significantly impact the company’s trajectory and share value.

Key Points from the EGM

• Major Acquisition Approved: Shareholders gave the green light to acquire the second floor of Tower A, Nobel Healthcare Park, in a deal classified as a major transaction under Chapter 10 of the Catalist Rules. This acquisition is set to expand the company’s healthcare footprint, with the rationale and benefits detailed in a circular dated August 15, 2025.
• Part Payment via Consideration Securities: The company will partially pay for the acquisition by issuing new securities—KLWC Warrants B and RCULS (Redeemable Convertible Unsecured Loan Stocks)—to the Vendor. This innovative payment method not only preserves cash but also introduces new securities to the market.
• Transfer of Controlling Interest to Vendor: The issuance of Consideration Securities will result in the Vendor gaining controlling interest in the company. This transfer, approved under Rule 803 of the Catalist Rules, marks a pivotal shift in corporate control and could influence future strategic direction.
• Corporate Rebranding: The company’s name will be officially changed from Beverly JCG Ltd. to Beverly Wilshire Ltd., signaling a new era and strategic repositioning in the healthcare sector.

Detailed Insights for Investors

1. Acquisition of Prime Healthcare Property

The acquisition of the second floor of Tower A, Nobel Healthcare Park, is expected to bolster Beverly’s asset base and operational capacity in the high-potential healthcare sector. The transaction was unanimously approved by shareholders, indicating strong support for the company’s growth ambitions.

2. Issuance of Consideration Securities: KLWC Warrants B & RCULS

Part of the acquisition will be funded through the issuance of KLWC Warrants B and RCULS. Notably, the Vendor will initially be the sole holder of these securities. KLWC Warrants B will require a minimum of 200 warrant holders for public listing, according to SGX-ST requirements. The RCULS carries a fixed coupon rate of 4% per annum, payable annually in arrears starting twelve months from issuance. Listing fees for the warrants will be approximately S\$7,500 for half a year. The timeline for listing the warrants will be determined in post-EGM discussions with the Vendor.

3. Transfer of Controlling Interest: Game-Changer for Governance

The controlling interest in Beverly JCG Ltd. will shift to the Vendor upon issuance of the Consideration Securities. This is a transformative development, as the new controlling shareholder could introduce strategic changes, new leadership, or operational pivots. The Vendor did not send a representative to the EGM, but management has committed to encouraging Vendor representation at future meetings to foster transparency and shareholder engagement.

4. Name Change to Beverly Wilshire Ltd.: Strategic Repositioning

The company’s rebranding to Beverly Wilshire Ltd. reflects a strategic shift and a new chapter in its corporate identity. This could signal broader ambitions and new business opportunities, especially in the healthcare and medical services landscape.

Shareholder Voting Results: Unanimous Approval

All resolutions were passed with a 100% approval rate. No shareholders abstained or voted against any of the proposals. Anton Management Solutions Pte. Ltd. acted as scrutineer for the polls.

Potential Price-Sensitive Developments

• Strategic Acquisition: Expansion in the healthcare sector with a prime property could drive future earnings growth.
• New Securities Issuance: Introduction of KLWC Warrants B and RCULS may impact share liquidity and capital structure.
• Controlling Shareholder Change: Potential for new strategic direction, leadership, or restructuring under Vendor’s control.
• Corporate Rebrand: A fresh identity may attract new investors and partners, boosting brand visibility.

What Investors Should Watch

• The timeline and final structure for the listing of KLWC Warrants B.
• Any immediate business or strategic changes following the transfer of controlling interest.
• Future engagement and communication from the new controlling shareholder.
• Market reaction to the company’s rebranding and asset expansion.

Conclusion

The EGM marks a watershed moment for Beverly JCG Ltd. (soon Beverly Wilshire Ltd.), with shareholders backing major moves that could significantly reshape the company’s future. Investors should closely monitor post-EGM developments, including warrant listing details, changes in management or strategy, and market sentiment towards the rebranding and asset acquisition. These events are potentially price sensitive and could drive future share value.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making investment decisions. The author and publisher are not responsible for any losses arising from reliance on the information provided herein.

View B Wilshire Ltd Historical chart here